RecruitingNCT06420219
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
Sponsor
University of Southern California
Enrollment
50 participants
Start Date
Mar 25, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Diagnosis/disease status: New diagnosis of head and neck cancer
- Allowable type and amount of prior therapy: No prior treatment
- Age ≥ 18 years.
- Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria1
- Patients who have had treatment of head and neck cancer
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06420219
Related Trials
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
NCT075563671 location
Oropharynx (OPX) Biomarker Trial
NCT063562721 location
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
NCT048707627 locations
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069745 locations
Cancer Genetic Testing in Ethnic Populations
NCT044756402 locations